Weill Cornell Medical College (WCMC) has established the Brain and Mind Research Institute (BMRI). The BMRI is directed by Dr. Costantino Iadecola, the Anne Parrish Titzell Professor of Neurology. A basic science entity with departmental privileges, the Institute provides a home for basic and clinical research focused on the brain and its diseases. Bridging the translational gap in the neurosciences is of paramount importance to public health. Owing to a convergence of scientific knowledge and technology, it is widely recognized that brain sciences are on the verge of numerous crucial breakthroughs, which will have a transformative impact not only on our understanding of the inner workings of the brain, but also on neurotherapeutics.
The institute conducts bench-to-bedside research to develop novel therapeutics for neurological diseases to be tested in cutting-edge clinical trials, as well as bedside-to-bench investigations to enhance current treatments and to truly bridge the current gap in translational medicine. Central to the institute's mission is the use and development of innovative preventive and diagnostic tools, leveraging advances in neuroimaging, genetics, genomics, epigenetics, metabolomics, computational biology and bioinformatics technology, as well as biomarkers for early disease detection and intervention. In addition, new preventive strategies will be developed to identify how individual risk factors may increase brain disease risk, and by studying the impact that comorbidities, such as hypertension and metabolic diseases, have on brain health.
With the Brain and Mind Research Institute, WCMC seeks to harness these dramatic advances to further enhance our position as a leading institution at the cutting edge of neuroscience research. Within the institute, basic and clinical neuroscientists are working side by side, sharing ideas, resources, and technology. The department of Neurology at Weill Cornell is a close partner in these efforts (Weill Cornell Medical College Department of Neurology). The resulting synergistic interactions are setting the stage for basic discoveries and advances elucidating disease mechanisms, as well as promoting new and more effective therapeutic approaches.